Unani medicine Habb-e-Sandroos for piles

Efficacy of Habb-e-Sandroos in Bawaseer Ghaira (Internal Hemorrhoids)

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/03/012550

Enrollment

Registered

2018-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- suffering from bawaseer-e-Ghaira(internal hemorrhoids)

Interventions

Intervention1: Habb-e-Samdroos: Hab-e-Sandroos, 2 tablets each weighing 0.5g, thrice in a day for the duration of protocol.

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed patients of Ist and IInd degree hemorrhoid confirmed by proctoscopy. 2.Patients of either sex. 3.Patients of 20-65 years of age. 4.Controlled Hypertensive Patients. 5.Controlled Diabetic Patients. ï?· Patients willing to participate in the study and ready to follow the protocol.

Exclusion criteria

Exclusion criteria: 1. III and IV degree internal hemorrhoids. 2. Patients with bleeding disorders. 3. Pregnant and lactating women. 4. Severe systemic illnesses.

Design outcomes

Secondary

Measure	Time frame
Mucus discharge (mild moderate severe mild moderate severe) ItchingTimepoint: 0 daay 15 day 30 day 45 day 1 month after completing protocol 2 months after completing protocol	—

Primary

Measure	Time frame
amount of bleeding regression of pile mass(grade-1, 2, 3, 4) bleeding points Timepoint: 0 day, 15th day 30th day 45th day After 1 month after protocol duration (after 1month by completing 45days) After 2 months by completing protocol duration	—

Countries

India

Contacts

Public ContactDr Mahfooz Alam

national institute of unani medicine

fatimahmehjabeen@gmail.com08057438462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026